Methods of inducing inflammatory bowel disease in mice

Current Protocols in Pharmacology

Volumn , Issue SUPPL.47, 2009, Pages

  Maxwell, Joseph R ^a   Brown, William A ^a   Smith, Carole L ^a   Byrne, Fergus R ^b   Viney, Joanne L ^b  

^a AMGEN INC   (United States)

^b AMGEN INC   (United States)

Author keywords

Colitis; IBD; Model; Mouse

Indexed keywords

CD45RB ANTIGEN; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 IMMUNOGLOBULIN FC FRAGMENT; DEXAMETHASONE; DEXTRAN SULFATE; HAPTEN; MULTIDRUG RESISTANCE PROTEIN 1; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; BACTERIUM CULTURE; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; COLITIS; CROHN DISEASE; DISEASE COURSE; DISEASE MODEL; DRUG SCREENING; ENTERITIS; HELICOBACTER BILIS; HELICOBACTER INFECTION; HISTOPATHOLOGY; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FEMALE; HELICOBACTER INFECTIONS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; SPECIMEN HANDLING; TRINITROBENZENESULFONIC ACID;

EID: 75949084489     PISSN: 19348282     EISSN: 19348290     Source Type: Journal    
DOI: 10.1002/0471141755.ph0558s47     Document Type: Review

References (65)

1. An, M.M., Fan, K.X., Zhang, J.D., Li, H.J., Song, S.C., Liu, B.G., Gao, P.H., Zhou, Q., and, Jiang, Y.Y., 2005. Lymphtoxin beta receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT/HVEM signaling. Pharmacol. Res. 52: 234 - 244.
2. Anthoni, C., Laukoetter, M.G., Rijcken, E., Vowinkel, T., Mennigen, R., Mller, S., Senninger, N., Russell, J., Jauch, J., Bergmann, J., Granger, D.N., and, Krieglstein, C.F., 2006. Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G1131 - G1137.
3. Aranda, R., Sydora, B.C., McAllister, P.L., Binder, S.W., Yang, H.Y., Targan, S.R., and, Kronenberg, M., 1997. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4, CD45RBhigh T cells to SCID recipients. J. Immunol. 158: 3464 - 3473.
4. Asseman, C., Mauze, S., Leach, M.W., Coffman, R.L., and, Powrie, F., 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190: 995 - 1003.
5. Atreya, R., Mudter, J., Finotto, S., Mullberg, J., Jostock, T., Wirtz, S., Schutz, M., Bartsch, B., Holtmann, M., Becker, C., Strand, D., Czaja, J., Schlaak, J.F., Lehr, H.A., Autschbach, F., Schrmann, G., Nishimoto, N., Yoshizaki, K., Ito, H., Kishimoto, T., Galle, P.R., Rose-John, S., and, Neurath, M.F., 2000. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo. Nat. Med. 6: 583 - 588.
6. Axelsson, L.G., Landstrom, E., Goldschmidt, T.J., Gronberg, A., and, Bylund-Fellenius, A.C., 1996. Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: Effects in CD4() -cell depleted, athymic and NK-cell depleted SCID mice. Inflamm. Res. 45: 181 - 191.
7. Banner, K.H., Cattaneo, C., Le Net, J.L., Popovic, A., Collins, D., and, Gale, J.D., 2004. Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene. Br. J. Pharmacol. 143: 590 - 598.
8. Billerey-Larmonier, C., Uno, J.K., Larmonier, N., Midura, A.J., Timmermann, B., Ghishan, F.K., and, Kiela, P.R., 2008. Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent. Inflamm. Bowel Dis. 14: 780 - 793.
9. Burich, A., Hershberg, R., Waggie, K., Zeng, W., Brabb, T., Westrich, G., Viney, J.L., and, Maggio-Price, L., 2001. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Am. J. Physiol. Gastrointest. Liver Physiol. 281: G764 - G778.
10. Cahill, R.J., Foltz, C.J., Fox, J.G., Dangler, C.A., Powrie, F., and, Schauer, D.B., 1997. Inflammatory bowel disease: An immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect. Immun. 65: 3126 - 3131.
11. Camoglio, L., te Velde, A.A., de Boer, A., ten Kate, F.J., Kopf, M., and, van Deventer, S.J., 2000. Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice. Eur. J. Immunol. 30: 1486 - 1495.
12. Camoglio, L., Juffermans, N.P., Peppelenbosch, M., te Velde, A.A., ten Kate, F.J., van Deventer, S. J., and, Kopf, M., 2002. Contrasting roles of IL-12p40 and IL-12p35 in the development of hapten-induced colitis. Eur. J. Immunol. 32: 261 - 269.
13. Daniel, C., Sartory, N.A., Zahn, N., Radeke, H.H., and, Stein, J.M., 2008. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther. 324: 23 - 33.
14. De Jong, Y.P., Comiskey, M., Kalled, S.L., Mizoguchi, E., Flavell, R.A., Bhan, A.K., and, Terhorst, C., 2000. Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration. Gastroenterology 119: 715 - 723.
15. Dieleman, L.A., Ridwan, B.U., Tennyson, G.S., Beagley, K.W., Bucy, R.P., and, Elson, C.O., 1994. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107: 1643 - 1652.
16. Elson, C.O., Beagley, K.W., Sharmanov, A.T., Fujihashi, K., Kiyono, H., Tennyson, G.S., Cong, Y., Black, C.A., Ridwan, B.W., and, McGhee, J.R., 1996. Hapten-induced model of murine inflammatory bowel disease: Mucosa immune responses and protection by tolerance. J. Immunol. 157: 2174 - 2185.
17. Fiedler, T., Buning, C., Reuter, W., Pitre, G., Gentz, E., Schmidt, H.H., Buttner, J., Ockenga, J., Gerloff, T., Meisel, C., Lochs, H., Roots, I., Kpke, K., and, Johne, A., 2007. Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohns disease. Eur. J. Clin. Pharmacol. 63: 917 - 925.
18. Fiorucci, S., Mencarelli, A., Palazzetti, B., Sprague, A.G., Distrutti, E., Morelli, A., Novobrantseva, T.I., Cirino, G., Koteliansky, V.E., and, de Fougerolles, A.R., 2002. Importance of innate immunity and collagen binding integrin alpha1beta1 in TNBS-induced colitis. Immunity 17: 769 - 780.
19. Foligne, B., Nutten, S., Steidler, L., Dennin, V., Goudercourt, D., Mercenier, A., and, Pot, B., 2006. Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: Technical and microbiological aspects. Dig. Dis. Sci. 51: 390 - 400.
20. Fox, J.G., Yan, L.L., Dewhirst, F.E., Paster, B.J., Shames, B., Murphy, J.C., Hayward, A., Belcher, J.C., and, Mendes, E.N., 1995. Helicobacter bilis sp. nov., a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice. J. Clin. Microbiol. 33: 445 - 454.
21. Gay, J., Kokkotou, E., OBrien, M., Pothoulakis, C., and, Karalis, K.P., 2006. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines. Neuroimmunomodulation 13: 114 - 121.
22. Hans, W., Scholmerich, J., Gross, V., and, Falk, W., 2000. The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur. J. Gastroenterol. Hepatol. 12: 267 - 273.
23. Ikenoue, Y., Tagami, T., and, Murata, M., 2005. Development and validation of a novel IL-10 deficient cell transfer model for colitis. Int. Immunopharmacol. 5: 993 - 1006.
24. Ishiguro, Y., Sakuraba, H., Yamagata, K., and, Munakata, A., 2004. The presentation of haptenated proteins and activation of T cells in the mesenteric lymph nodes by dendritic cells in the TNBS colitis rat. Ann. N.Y. Acad. Sci. 1029: 346 - 347.
25. Ito, R., Shin-Ya, M., Kishida, T., Urano, A., Takada, R., Sakagami, J., Imanishi, J., Kita, M., Ueda, Y., Iwakura, Y., Kataoka, K., Okanoue, T., and, Mazda, O., 2006. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin. Exp. Immunol. 146: 330 - 338.
26. Jergens, A.E., Wilson-Welder, J.H., Dorn, A., Henderson, A., Liu, Z., Evans, R.B., Hostetter, J., and, Wannemuehler, M.J., 2007. Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice. Gut 56: 934 - 940.
27. Kojouharoff, G., Hans, W., Obermeier, F., Mnnel, D.N., Andus, T., Schlmerich, J., Gross, V., and, Falk, W., 1997. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin. Exp. Immunol. 107: 353 - 358
28. Kullberg, M.C., Ward, J.M., Gorelick, P.L., Caspar, P., Hieny, S., Cheever, A., Jankovic, D., and, Sher, A., 1998. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect. Immun. 66: 5157 - 5166.
29. Leach, M.W., Bean, A.G., Mauze, S., Coffman, R.L., and, Powrie, F., 1996. Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4 T cells. Am. J. Pathol. 148: 1503 - 1515.
30. Liu, Z., Geboes, K., Heremans, H., Overbergh, L., Mathieu, C., Rutgeerts, P., and, Ceuppens, J.L., 2001. Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis. Eur. J. Immunol. 31: 1550 - 1560.
31. Maggio-Price, L., Shows, D., Waggie, K., Burich, A., Zeng, W., Escobar, S., Morrissey, P., and, Viney, J.L., 2002. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a -/-) mice. Am. J. Pathol. 160: 739 - 751.
32. Maggio-Price, L., Bielefeldt-Ohmann, H., Treuting, P., Iritani, B.M., Zeng, W., Nicks, A., Tsang, M., Shows, D., Morrissey, P., and, Viney, J.L., 2005. Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a -/- mice results in colitis that progresses to dysplasia. Am. J. Pathol. 166: 1793 - 1806.
33. Mahler, M., Bristol, I.J., Leiter, E.H., Workman, A.E., Birkenmeier, E.H., Elson, C.O., and, Sundberg, J.P., 1998. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am. J. Physiol. 274: G544 - G551.
34. Melgar, S., Karlsson, A., and, Michaelsson, E., 2005. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: Correlation between symptoms and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 288: G1328 - G1338.
35. Morrissey, P.J., Charrier, K., Braddy, S., Liggitt, D., and, Watson, J.D., 1993. CD4 T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice: Disease development is prevented by cotransfer of purified CD4 T cells. J. Exp. Med. 178: 237 - 244.
36. Morrissey, P.J., and, Charrier, K., 1994. Induction of wasting disease in SCID mice by the transfer of normal CD4/CD45RBhi T cells and the regulation of this autoreactivity by CD4/CD45RBlo T cells. Res. Immunol. 145: 357 - 362.
37. Murata, H., Tsuji, S., Tsujii, M., Fu, H.Y., Tanimura, H., Tsujimoto, M., Matsuura, N., Kawano, S., and, Hori, M., 2004. Helicobacter bilis infection in biliary tract cancer. Aliment. Pharmacol. Ther. 20: 90 - 94.
38. Myers, K.J., Murthy, S., Flanigan, A., Witchell, D.R., Butler, M., Murray, S., Siwkowski, A., Goodfellow, D., Madsen, K., and, Baker, B., 2003. Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis. J. Pharmacol. Exp. Ther. 304: 411 - 424.
39. Naito, Y., Takagi, T., Uchiyama, K., Kuroda, M., Kokura, S., Ichikawa, H., Yanagisawa, R., Inoue, K., Takano, H., Satoh, M., Yoshida, N., Okanoue, T., and, Yoshikawa, T., 2004. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice. Int. J. Mol. Med. 14: 191 - 196.
40. Neurath, M.F., Fuss, I., Kelsall, B.L., Stuber, E., and, Strober, W., 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182: 1281 - 1290.
41. Neurath, M.F., Fuss, I., Pasparakis, M., Alexopoulou, L., Haralambous, S., Meyer zum Buschenfelde, K.H., Strober, W., and, Kollias, G., 1997. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur. J. Immunol. 27: 1743 - 1750.
42. Obermeier, F., Kojouharoff, G., Hans, W., Schlmerich, J., Gross, V., and, Falk, W., 1999. Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin. Exp. Immunol. 116: 238 - 245.
43. Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y., and, Nakaya, R., 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694 - 702.
44. Panwala, C.M., Jones, J.C., and, Viney, J.L., 1998. A novel model of inflammatory bowel disease: Mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J. Immunol. 161: 5733 - 5744.
45. Powrie, F., Leach, M.W., Mauze, S., Caddle, L.B., and, Coffman, R.L., 1993. Phenotypically distinct subsets of CD4 T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5: 1461 - 1471.
46. Powrie, F., Leach, M.W., Mauze, S., Menon, S., Caddle, L.B., and, Coffman, R.L., 1994. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4 T cells. Immunity 1: 553 - 562.
47. Powrie, F., Mauze, S., and, Coffman, R.L., 1997. CD4 T-cells in the regulation of inflammatory responses in the intestine. Res. Immunol. 148, 576 - 581.
48. Rojas-Cartagena, C., Flores, I., and, Appleyard, C.B., 2005. Role of tumor necrosis factor receptors in an animal model of acute colitis. Cytokine 32: 85 - 93.
49. Sainathan, S.K., Hanna, E.M., Gong, Q., Bishnupuri, K.S., Luo, Q., Colonna, M., White, F.V., Croze, E., Houchen, C., Anant, S., and, Dieckgraefe, B.K., 2008. Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. Inflamm. Bowel Dis. 14: 88 - 99.
50. Scheiffele, F., and, Fuss, I.J., 2001. Induction of TNBS colitis in mice. Curr. Protoc. Immunol. 49: 15.19.1 - 15.19.14.
51. Schinkel, A.H., Smit, J.J., van Tellingen, O., Beijnen, J.H., Wagenaar, E., van Deemter, L., Mol, C.A., van der Valk, M.A., Robanus-Maandag, E.C., te Riele, H.P., Berns, A.J.M, and, Borst, P., 1994. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77: 491 - 502.
52. Schon, M.P., Detmar, M., and, Parker, C.M., 1997. Murine psoriasis-like disorder induced by naive CD4 T cells. Nat. Med. 3: 183 - 188.
53. Schwab, M., Schaeffeler, E., Marx, C., Fromm, M.F., Kaskas, B., Metzler, J., Stange, E., Herfarth, H., Schoelmerich, J., Gregor, M., Walker, S., Cascorbi, I., Roots, I., Brinkmann, U., Zanger, U.M., and, Eichelbaum, M., 2003. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 124: 26 - 33.
54. Shomer, N.H., Dangler, C.A., Schrenzel, M.D., and, Fox, J.G., 1997. Helicobacter bilisinduced inflammatory bowel disease in scid mice with defined flora. Infect. Immun. 65: 4858 - 4864.
55. Soriano-Izquierdo, A., Gironella, M., Massaguer, A., Salas, A., Gil, F., Piqu, J.M., and, Pans, J., 2004. Effect of cyclosporin A on cell adhesion molecules and leukocyte-endothelial cell interactions in experimental colitis. Inflamm. Bowel Dis. 10: 789 - 900.
56. Stallmach, A., Marth, T., Weiss, B., Wittig, B.M., Hombach, A., Schmidt, C., Neurath, M., Zeitz, M., Zeuzem, S., and, Abken, H., 2004. An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: Anti-inflammatory activity in Crohns disease and experimental colitis in vivo. Gut 53: 339 - 345.
57. Strober, W., Fuss, I., Boirivant, M., and, Kitani, A., 2004. Insights into the mechanism of oral tolerance derived from the study of models of mucosal inflammation. Ann. N.Y. Acad. Sci. 1029: 115 - 131.
58. Takagi, H., Kanai, T., Okazawa, A., Kishi, Y., Sato, T., Takaishi, H., Inoue, N., Ogata, H., Iwao, Y., Hoshino, K., Takeda, K., Akira, S., Watanabe, M., Ishii, H., and, Hibi, T., 2003. Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice. Scand. J. Gastroenterol. 38: 837 - 844.
59. Takedatsu, H., Michelsen, K.S., Wei, B., Landers, C.J., Thomas, L.S., Dhall, D., Braun, J., and, Targan, S.R., 2008. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 135: 552 - 567.
60. te Velde, A.A., Verstege, M.I., and, Hommes, D.W., 2006. Critical appraisal of the current practice in murine TNBS-induced colitis. Inflamm. Bowel Dis. 12: 995 - 999.
61. Totsuka, T., Kanai, T., Uraushihara, K., Iiyama, R., Yamazaki, M., Akiba, H., Yagita, H., Okumura, K., and, Watanabe, M., 2003. Therapeutic effect of anti-OX40L and anti-TNF-alpha MAbs in a murine model of chronic colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G595 - 603.
62. Voytas, D., 2000. Agarose gel electrophoresis. Curr. Protoc. Mol. Biol. 51: 2.5A.1 - 2.5A.9.
63. Ward, J.M., Anver, M.R., Haines, D.C., Melhorn, J.M., Gorelick, P., Yan, L., and, Fox, J.G., 1996. Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus. Lab. Anim. Sci. 46: 15 - 20.
64. Wilk, J.N., Bilsborough, J., and, Viney, J.L., 2005. The mdr1a -/- mouse model of spontaneous colitis: A relevant and appropriate animal model to study inflammatory bowel disease. Immunol. Res. 31: 151 - 159.
65. Wirtz, S., Neufert, C., Weigmann, B., and, Neurath, M.F., 2007. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2: 541 - 546.